Since increased production of ROS, followed by upregulation of MTH1, is seen in proliferating T cells, which orchestrate allergic inflammation, MTH1 may provide a novel therapeutic target in allergic asthma [9, 14]. The gene discussed is NUDT1; the disease is allergic asthma.